Industry Trend

Thyroid Eye Disease (TED) is a rare but serious autoimmune condition that affects the tissues around the eyes, often leading to inflammation, pain, vision changes, and reduced quality of life. As new therapies have emerged, particularly biologic infusion treatments, patients finally have access to improved outcomes. But with these advancements comes a significant rise in…

Nashville, TN — Oct. 29, 2025 – Golden Triangle Specialty Network (GTSN), a leader in specialty pharmacy cost management, today announced the launch of GTRx Plus, a comprehensive carve-out program designed to help health plans control the soaring costs of specialty drugs billed under J-codes. Specialty medications represent one of the fastest-growing segments of healthcare…

The Cost Saving Power of Generic Equivalents in Specialty Infusion Medications Specialty infusion drugs are some of the most expensive treatments in healthcare. For many health plans and employers, they drive a disproportionate share of pharmacy and medical costs, even though they serve a relatively small patient population. One way to manage this growing expense?…

Specialty medications represent one of the fastest-growing and most expensive areas of healthcare. For many health plans and employers, these drugs account for a disproportionate share of total pharmacy spend, often exceeding 50% of overall drug costs despite serving a small percentage of members. That’s where carveouts come in. They help manage specialty pharmacy spend…

When talking about kidney disease, it’s easy to focus on treatment, but at Golden Triangle Specialty Network (GTSN), we like to focus on prevention. With over 1 in 7 adults in the U.S. living with chronic kidney disease (CKD), and many unaware they have it, preventing the condition before it starts is more important than…

As specialty drug costs continue to rise, the pressure on employers, benefit administrators, and patients has never been greater. Golden Triangle Specialty Network (GTSN) is committed to helping stakeholders achieve the delicate balance between economic sustainability and high-quality patient care. By aligning financial strategy with patient outcomes, we support a smarter, more responsible approach to…

An estimated 133 million Americans are currently suffering from a chronic illness, such as hypertension, heart disease, and arthritis. That’s nearly half the population. It’s likely that someone close to you is silently navigating life with a chronic condition and potentially suffering from the effects of that condition every single day. In addition to the…

The landscape of healthcare continues to evolve rapidly, presenting complex challenges in balancing cost management with high-quality care delivery. At Golden Triangle Specialty Network (GTSN), we are dedicated to navigating these complexities by developing sustainable solutions that prioritize patient outcomes without compromising financial viability. Our approach is particularly relevant in the context of dialysis, a…

The healthcare industry is navigating a period of rapid change, where managing costs and delivering quality care often feel at odds. Among the challenges faced by payors, patients, and providers is the issue of balance billing—a practice that can strain relationships and financial outcomes alike. At Golden Triangle Specialty Network (GTSN), we are committed to…

The specialty pharmaceutical market is exploding, projected to grow from $68.3 billion in 2023 to $1.53 trillion by 2033.1 While innovation drives advanced treatments for complex conditions, skyrocketing costs pose challenges for payors and providers. Golden Triangle Specialty Network (GTSN) offers unmatched cost management solutions, helping stakeholders navigate this evolving landscape with savings-focused strategies in…